FDA Inspection 1095039 — Christus Spohn Hospital Corpus Christi
The FDA completed an inspection of Christus Spohn Hospital Corpus Christi on June 4, 2019 in Corpus Christi, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 4, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Corpus Christi, TX (United States)